LENZ Therapeutics Inc. logo

LENZ Therapeutics Inc.

LENZ | NASDAQ
Chart Builder DCF Calculator
$4.08
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$4.08
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$127.61M
Enterprise Value
$-91.96M
Beta
1.63
Average Volume
854.64K
Shares Outstanding (Diluted)
31.37M
Shares Change YoY
11.74%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US52635N1037

Price Performance

Price Change 1M
-12.4%
Price Change 3M
-29.0%
Price Change 6M
-55.0%
Price Change YTD
-74.5%
Price Change 1Y
-90.1%
Price Change 3Y
-74.8%
Price Change 5Y
-74.8%
1M CAGR (ann.)
-22.0%
1Y CAGR (ann.)
-90.4%
5Y CAGR (ann.)
-31.9%
All-Time CAGR
-29.6%

Valuation

PE Ratio
-1.00
Forward PE
N/A
PEG Ratio
0.02
Forward PEG
0.03
PS Ratio
5.96
Forward PS
3.00
PB Ratio
0.58
P/FCF Ratio
-1.12
P/Adj. FCF Ratio
-1.01
P/OCF Ratio
-1.12
EV/Sales
-4.28
EV/EBIT
0.73
EV/EBITDA
0.73
EV/FCF
0.80
Earnings Yield
-100.3%
FCF Yield
-89.4%
Adj. FCF Yield
-98.5%

Financial Health

Net Cash
$220M
Total Debt
$122K
Cash & Short-Term Investments
$220M
Total Assets
$236.6M
Current Ratio
13.55
Quick Ratio
13.31
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
-933.67
Interest Coverage
0.00
Altman Z-Score
2.07
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
90.1%
Operating Profit Margin
-631.7%
EBITDA Margin
-584.6%
Net Profit Margin
-586.7%
FCF Margin
-532.8%
Adj. FCF Margin
-586.9%
SBC / Revenue
54.1%
SBC Impact (per share)
-10.2%

Returns

Return on Assets
-53.3%
Return on Equity
-53.4%
Return on Invested Capital
-61.8%
Return on Capital Employed
-61.8%
Return on Tangible Assets
-53.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
121.7%
Revenue CAGR 5Y
90.6%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
52.1%
EPS CAGR 5Y
32.7%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-25.7%
FCF CAGR 5Y
-8.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
30.4%
Revenue Growth Next 3Y
89.3%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$1.02
EPS Growth Est (next Q)
72.9%
Revenue Est (next Q)
$4.49M
Revenue Growth Est (next Q)
-64.1%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7
Price Target Upside
71.6%

Cash Flow

Operating Cash Flow
$-113.91M
Free Cash Flow
$-114.42M
Adj. Free Cash Flow
$-126.04M
FCF Per Share
-$3.65
OCF Per Share
-$3.63
OCF/S Ratio
-530.4%

Income Statement

Revenue
$21.48M
Gross Profit
$19.36M
Operating Income
$-135.66M
EBITDA
$-125.54M
Net Income
$-126M
EPS (Diluted)
-$4.09
Revenue / Employee
$141.28K
Profit / Employee
$-828.96K
Employees
152

© 2026 bestshares.com. All rights reserved.